Editorial: Methods and application in cardiovascular and smooth muscle pharmacology: 2021
Front Pharmacol
.
2022 Oct 21:13:1049022.
doi: 10.3389/fphar.2022.1049022.
eCollection 2022.
Authors
Ahmed F El-Yazbi
1
2
,
Ali H Eid
3
,
Fouad A Zouein
4
5
6
7
,
Khaled S Abd-Elrahman
1
8
9
Affiliations
1
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
2
Faculty of Pharmacy, Alamein International University, Al Alamein, Egypt.
3
Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
4
Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
5
Department of Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Inserm, Université Paris-Saclay, Paris-Saclay, France.
6
The Cardiovascular Renal and Metabolic Diseases Research Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
7
Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
8
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
9
Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.
PMID:
36339565
PMCID:
PMC9634541
DOI:
10.3389/fphar.2022.1049022
No abstract available
Keywords:
biomarkers; biomedical research; cardiovasclar disease; disease outcome; natural products.
Publication types
Editorial